-transparent.png){kind=logo}
1. The mechanism of increased renin activity after human plasma had been kept at -5 degrees C for 4 days (cryoactivation) was investigated. 2. The increase in renin activity of human plasma by cryoactivation was closely correlated to the increase obtained by incubation with trypsin (r = 0.88, P less than 0.001, n = 10). 3. An inhibitor of thiol enzyme, N-ethylmaleimide did not inhibit cryoactivation. 4. Soyabean trypsin inhibitor and di-isopropylflurophosphate (DFP) inhibited cryoactivation, suggesting that the cryoactivation may be due to the action of a trypsin-like serine enzyme. 5. In an experiment in the rat haemorrhagic shock caused parallel and cryoactivated plasma, the renin activity being about two times higher in the latter. No significant differences were found in the concentrations of renin and renin substrate between the non-cryoactivated and cryoactivated plasma samples. 6. The results may indicate that a destruction of an inhibitor of the renin-renin substrate reaction is responsible for the increase of renin activity after exposure of rat plasma to low temperature. A trypsin-like enzyme in plasma might have destroyed the inhibitor during this procedure.
A Hara, and
M Matsunaga, and
J Yamamoto, and
K Morimoto, and
H Nagai, and
K Kanatsu, and
C H Pak, and
K Ogino, and
C Kawai
May 1978,
Archives internationales de physiologie et de biochimie,
A Hara, and
M Matsunaga, and
J Yamamoto, and
K Morimoto, and
H Nagai, and
K Kanatsu, and
C H Pak, and
K Ogino, and
C Kawai
May 1979,
Klinische Wochenschrift,
A Hara, and
M Matsunaga, and
J Yamamoto, and
K Morimoto, and
H Nagai, and
K Kanatsu, and
C H Pak, and
K Ogino, and
C Kawai
October 1991,
Journal of the Formosan Medical Association = Taiwan yi zhi,
A Hara, and
M Matsunaga, and
J Yamamoto, and
K Morimoto, and
H Nagai, and
K Kanatsu, and
C H Pak, and
K Ogino, and
C Kawai
January 1982,
Clinical and experimental pharmacology & physiology,
A Hara, and
M Matsunaga, and
J Yamamoto, and
K Morimoto, and
H Nagai, and
K Kanatsu, and
C H Pak, and
K Ogino, and
C Kawai
November 1976,
The American journal of medicine,
A Hara, and
M Matsunaga, and
J Yamamoto, and
K Morimoto, and
H Nagai, and
K Kanatsu, and
C H Pak, and
K Ogino, and
C Kawai
July 2023,
Clinical chemistry and laboratory medicine,
A Hara, and
M Matsunaga, and
J Yamamoto, and
K Morimoto, and
H Nagai, and
K Kanatsu, and
C H Pak, and
K Ogino, and
C Kawai
July 1981,
Clinica chimica acta; international journal of clinical chemistry,
A Hara, and
M Matsunaga, and
J Yamamoto, and
K Morimoto, and
H Nagai, and
K Kanatsu, and
C H Pak, and
K Ogino, and
C Kawai
November 1979,
Clinical chemistry,
A Hara, and
M Matsunaga, and
J Yamamoto, and
K Morimoto, and
H Nagai, and
K Kanatsu, and
C H Pak, and
K Ogino, and
C Kawai
July 1979,
Clinica chimica acta; international journal of clinical chemistry,
A Hara, and
M Matsunaga, and
J Yamamoto, and
K Morimoto, and
H Nagai, and
K Kanatsu, and
C H Pak, and
K Ogino, and
C Kawai
January 1982,
Hypertension (Dallas, Tex. : 1979),
